Related references
Note: Only part of the references are listed.Epidemiology of Cardiac Amyloidosis-Associated Heart Failure Hospitalizations Among Fee-for-Service Medicare Beneficiaries in the United States
Lauren G. Gilstrap et al.
CIRCULATION-HEART FAILURE (2019)
Prevalence of wild type ATTR assessed as myocardial uptake in bone scan in the elderly population
Laroussi Mohamed-Salem et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2018)
Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy
Mathew S. Maurer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Epidemiology of AL amyloidosis: a real-world study using US claims data
Tiffany P. Quock et al.
BLOOD ADVANCES (2018)
Heart Failure Resulting From Age-Related Cardiac Amyloid Disease Associated With Wild-Type Transthyretin A Prospective, Observational Cohort Study
Lawreen H. Connors et al.
CIRCULATION (2016)
Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis
Julian D. Gillmore et al.
CIRCULATION (2016)
Natural History of Wild-Type Transthyretin Cardiac Amyloidosis and Risk Stratification Using a Novel Staging System
Martha Grogan et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2016)
Wild-type transthyretin amyloidosis as a cause of heart failure with preserved ejection fraction
Esther Gonzalez-Lopez et al.
EUROPEAN HEART JOURNAL (2015)
Left Ventricular Amyloid Deposition in Patients With Heart Failure and Preserved Ejection Fraction
Selma F. Mohammed et al.
JACC-HEART FAILURE (2014)
Senile Systemic Amyloidosis: Clinical Features at Presentation and Outcome
Jennifer H. Pinney et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2013)
Share Paper
